Carolyn Clevenger
Gerontology · Atlanta, GANPI 1255547907
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $52,253 of the $64,794 with a category attached, or 80.6%. 12 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 30.9% of the total. Among gerontology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $719.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$20K
- Lilly USA, LLC$18K
- Novo Nordisk$7K
- Genentech, Inc.$6K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$6K
- Genentech USA, Inc.$4K
- plus $3K from 6 others
What the payments were for
- Consulting fees$52,25381%
- Speaking & faculty fees$3,8506%
- Travel & lodging$5,7559%
- Food & beverage$2,9355%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $19,998 |
| Lilly USA, LLC | 40 | $18,458 |
| Novo Nordisk | 6 | $7,179 |
| Genentech, Inc. | 5 | $6,090 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 6 | $5,715 |
| Genentech USA, Inc. | 2 | $3,903 |
| Roche Products Limited | 1 | $2,800 |
| Corium, LLC | 2 | $181 |
| Eisai Inc. | 2 | $139 |
| Scpharmaceuticals Inc. | 1 | $124 |
| Acadia Pharmaceuticals Inc | 1 | $112 |
| Mylan Specialty L.p. | 1 | $95 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$64,794 in reported general payments places this provider in the 95th percentile of 197 gerontology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $5,615 |
| Memantine Hcl | 86 | $5,387 |
| Memantine Hcl ErMemantine Hcl | 22 | $1,105 |
| Galantamine ErGalantamine Hbr | 11 | $1,002 |
| Famotidine | 30 | $943 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $763 |
| Mirtazapine | 22 | $705 |
| Atorvastatin Calcium | 50 | $654 |
| Nifedipine ErNifedipine | 16 | $556 |
| Donepezil Hcl | 55 | $554 |
| Rosuvastatin Calcium | 13 | $517 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 26 | $513 |
| Tamsulosin Hcl | 17 | $455 |
| Doxycycline Hyclate | 13 | $424 |
| Amlodipine Besylate | 57 | $415 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Atlanta
- Mitzi LewisAtlanta$37K
- Constance MeinkenAtlanta$36K
- Kathleen BradfordAtlanta$8K
- Virginia KeatingAtlanta$5K
- Robin BrownAtlanta$5K
- Julia VargheseAtlanta$4K
- Mirali PatelAtlanta$4K
- Radha SamtaniAtlanta$4K
- Brittany HaynesAtlanta$3K
- Victoria HutsonAtlanta$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.